Montaudon, E., Nikitorowicz-Buniak, J., Sourd, L., Morisset, L., Botty, R. E., Huguet, L., . . . Marangoni, E. (2020). PLK1 inhibition exhibits strong anti-tumoral activity in CCND1-driven breast cancer metastases with acquired palbociclib resistance. Nature Publishing Group.
Chicago Style (17th ed.) CitationMontaudon, Elodie, et al. PLK1 Inhibition Exhibits Strong Anti-tumoral Activity in CCND1-driven Breast Cancer Metastases with Acquired Palbociclib Resistance. Nature Publishing Group, 2020.
MLA (8th ed.) CitationMontaudon, Elodie, et al. PLK1 Inhibition Exhibits Strong Anti-tumoral Activity in CCND1-driven Breast Cancer Metastases with Acquired Palbociclib Resistance. Nature Publishing Group, 2020.
Warning: These citations may not always be 100% accurate.